Comparison between the effects of implantable gestrinone and oral dienogest in the treatment of endometriosis: randomized controlled clinical trial

André Vinícius de Assis Florentino, Juliana Bicca Nascimento, José M. P. Nascimento, Juliana Bezerra Medeiros de Lima, Giovanna Milhomem Ignacio, Garc a De La Torre Ignacio, Guilherme Renke, Carlos Rodrigo de Mello Roesler, Izabelle M. Gindri, Darlan Dallacosta
In: Maturitas · 2025 · vol. 199 , pp. 108519 · doi:10.1016/j.maturitas.2025.108519 · W4412930292
article OA: closed CC0
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex
⚙ AI-generated summary by qwen3.7-flash, 2026-09-20 ⓘ

This randomized controlled clinical trial compared the therapeutic effects of implantable gestrinone versus oral dienogest for treating endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall
last seen: 2026-09-24T06:17:16.569905+00:00
License: CC0 · commercial use OK